CureVac N.V. provided its financial results for the first quarter of 2025 along with business updates. The press release includes forward-looking statements about the company’s vaccine and treatment candidates, strategies, financing plans, cash runway expectations, regulatory approval, growth opportunities, and market growth. These statements are based on current beliefs and assumptions but are subject to […]